✦ LIBER ✦

ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells

✍ Scribed by Wu, J; Meng, F; Ying, Y; Peng, Z; Daniels, L; Bornmann, W G; Quintás-Cardama, A; Roulston, D; Talpaz, M; Peterson, L F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of dual-specific Bcr-Abl and Sr

✍ Tipping, A J; Baluch, S; Barnes, D J; Veach, D R; Clarkson, B M; Bornmann, W G; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Effect of a selective Abl tyrosine kinas

✍ Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 546 KB

Effects of the Tyrosine Kinase Inhibitor

✍ Toshio Nishihara; Yasuo Miura; Yumi Tohyama; Chisato Mizutani; Terutoshi Hishita 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 712 KB

A novel mechanism for imatinib mesylate

✍ Takatsune Shimizu; Yoshitaka Miyakawa; Satoshi Iwata; Akiko Kuribara; Tony Tigan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 315 KB

The in vitro activity of the tyrosine ki

✍ Liu, W M; Stimson, L A; Joel, S P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Imatinib resistance in a novel transloca

✍ Katsuya Yamamoto; Kimikazu Yakushijin; Shinichiro Nishikawa; Kentaro Minagawa; Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 733 KB